top of page

Hospitals, insurers want rebate rule changed to keep pharma honest

Insurers and hospitals want the CMS to amend its proposed rule eliminating the safe harbor for Medicare Part D and Medicaid managed-care drug rebates to include new requirements for drugmakers.

保險公司和醫院希望CMS修改其擬議規則,取消Medicare D部分和醫療補助管理醫療藥品退稅的保護條例,以及加入對製藥商的新要求。


The new rule would create a system "in which transparent, upfront discounts benefit patients, rather than a system driven by rebates that may not be used to directly benefit patients using the medicines for which the rebate is paid"

新規則將創建一個”透明系統",使患者受益的前期折扣系統,而不是透過回扣的系統,因回扣系統可能不會直接讓使用藥物的患者受益


若您有更多關於健康保險的相關問題,歡迎諮詢! If you have more question about health insurance, feel free to contact us!


電話 Phone: 626-912-1988 Email: 1234@ppo-hmo.com




0 views0 comments
bottom of page